Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20180120038450N3Phase 3Completed
Phase 3, single-blind trial of zolpidem in Insomnia (2 arms), sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Sleep quality. Started Jan 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20180120038450N3.